Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection.

Abstract : Elicitation of type I interferon (IFN-I) has been shown to both enhance and impair cell-mediated immune responses in acute and persistent viral infections, respectively. Here, we show that, in addition to its effect on T cells, IFN-I drives impairment of specific antibody responses through interaction with B cells in the acute phase of lymphocytic choriomeningitis virus (LCMV) infection. This impairment was limited to the T cell-dependent B cell response and was associated with disruption of B cell follicles, development of hypergammaglobulinemia (HGG), and expansion of the T follicular helper cell population. Antigen-specific antibody responses were restored by ablation of IFN-I signaling through antibody-mediated IFN-I receptor blockade and B cell-specific IFN-I receptor knockout. Importantly, IFN-I receptor deficiency in B cells also accelerated the development of LCMV neutralizing antibodies and alleviated HGG. These results provide a potential therapeutic target toward efficient treatment measures that limit immunopathology in persistent viral infections.
Type de document :
Article dans une revue
Frontiers in Immunology, Frontiers, 2016, 7, pp.564. 〈10.3389/fimmu.2016.00564〉
Liste complète des métadonnées

Littérature citée [29 références]  Voir  Masquer  Télécharger

https://hal-riip.archives-ouvertes.fr/pasteur-01535181
Contributeur : Michel Courcelles <>
Soumis le : jeudi 8 juin 2017 - 19:56:28
Dernière modification le : lundi 8 octobre 2018 - 17:44:05
Document(s) archivé(s) le : mercredi 13 décembre 2017 - 06:26:59

Fichier

fimmu-07-00564.pdf
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

Citation

Matthieu Daugan, Armstrong Murira, Barbara C Mindt, Amélie Germain, Esther Tarrab, et al.. Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection.. Frontiers in Immunology, Frontiers, 2016, 7, pp.564. 〈10.3389/fimmu.2016.00564〉. 〈pasteur-01535181〉

Partager

Métriques

Consultations de la notice

25

Téléchargements de fichiers

31